ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,071.17
      0.53%
      US Tech 100
      21,008.00
      0.84%
      Dow Jones
      44,882.13
      0.38%
      Brent Oil
      76.315
      0.35%
      Bitcoin
      104,388.15
      -0.33%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Neurocrine Biosciences Inc (0K6R) Quote

      Neurocrine Biosciences Inc

      Neurocrine Biosciences Inc (0K6R)

      LSE
      91.67
      0.00
      (0.00%)
      Closed January 30 11:30AM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      91.67
      Bid
      0.00
      Ask
      0.00
      Volume
      1,816
      0.00 Day's Range 0.00
      91.67 52 Week Range 91.67
      Market Cap
      9.007B
      Previous Close
      91.67
      Open
      -
      Last Trade
      1
      @
      153.82
      (O)
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      1,124
      Shares Outstanding
      98,252,000
      Dividend Yield
      -
      PE Ratio
      60.34
      Earnings Per Share (EPS)
      2.54
      Revenue
      1.89B
      Net Profit
      249.7M

      About Neurocrine Biosciences Inc

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.neurocrine.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Neurocrine Biosciences Inc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker 0K6R. The last closing price for Neurocrine Biosciences was $91.67. Over the last year, Neurocrine Biosciences shares have traded in a share price range of $ 91.67 to $ 91.67.

      Neurocrine Biosciences currently has 98,252,000 shares outstanding. The market capitalization of Neurocrine Biosciences is $9.01 billion. Neurocrine Biosciences has a price to earnings ratio (PE ratio) of 60.34.

      Ask ADVFN Intelligence (AI)

      0K6R Latest News

      More News

      Diurnal Group PLC EXERCISE OF OPTIONS

      Diurnal Group PLC 28 October 2022 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT...

      October 28 2022
      UK Regulatory

      Diurnal Group PLC COURT SANCTION OF SCHEME OF ARRANGEMENT

      Diurnal Group PLC 28 October 2022 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT...

      October 28 2022
      UK Regulatory

      Diurnal Group PLC Form 8.3 - IPG - Diurnal Group PLC

      Diurnal Group PLC 08 September 2022 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the...

      September 08 2022
      UK Regulatory

      Stifel Nicolaus Europe Limited Form 8.5 (EPT/RI) - Diurnal Group plc

      Stifel Nicolaus Europe Limited 08 September 2022 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY...

      September 08 2022
      UK Regulatory

      Stifel Nicolaus Europe Limited Form 8.5 (EPT/RI) - Diurnal Group plc

      Stifel Nicolaus Europe Limited 07 September 2022 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY...

      September 07 2022
      UK Regulatory

      Stifel Nicolaus Europe Limited Form 8.5 (EPT/RI) - Diurnal Group plc

      Stifel Nicolaus Europe Limited 06 September 2022 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY...

      September 06 2022
      UK Regulatory

      Diurnal Group PLC Form 8 (OPD) (Diurnal Group)

      Diurnal Group PLC 05 September 2022 FORM 8 (OPD) PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER Rules 8.1 and 8.2 of the Takeover Code (the "Code") 1. KEY INFORMATION (a...

      September 05 2022
      UK Regulatory

      Stifel Nicolaus Europe Limited Form 8.5 (EPT/RI) - Diurnal Group plc

      Stifel Nicolaus Europe Limited 05 September 2022 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY...

      September 05 2022
      UK Regulatory

      Stifel Nicolaus Europe Limited Form 8.5 (EPT/RI) - Diurnal Group plc

      Stifel Nicolaus Europe Limited 02 September 2022 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY...

      September 02 2022
      UK Regulatory

      Stifel Nicolaus Europe Limited Form 8.5 (EPT/RI) - Diurnal Group plc

      Stifel Nicolaus Europe Limited 01 September 2022 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY...

      September 01 2022
      UK Regulatory
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10091.6791.6791.67108091.67DE
      40091.6791.6791.67102491.67DE
      120091.6791.6791.67112491.67DE
      260091.6791.6791.6778191.67DE
      520091.6791.6791.6755291.67DE
      1560091.6791.6791.67127591.67DE
      2600091.6791.6791.6780491.67DE

      0K6R - Frequently Asked Questions (FAQ)

      What is the current Neurocrine Biosciences share price?
      The current share price of Neurocrine Biosciences is $ 91.67
      How many Neurocrine Biosciences shares are in issue?
      Neurocrine Biosciences has 98,252,000 shares in issue
      What is the market cap of Neurocrine Biosciences?
      The market capitalisation of Neurocrine Biosciences is USD 9.01B
      What is the 1 year trading range for Neurocrine Biosciences share price?
      Neurocrine Biosciences has traded in the range of $ 91.67 to $ 91.67 during the past year
      What is the PE ratio of Neurocrine Biosciences?
      The price to earnings ratio of Neurocrine Biosciences is 60.34
      What is the cash to sales ratio of Neurocrine Biosciences?
      The cash to sales ratio of Neurocrine Biosciences is 7.98
      What is the reporting currency for Neurocrine Biosciences?
      Neurocrine Biosciences reports financial results in USD
      What is the latest annual turnover for Neurocrine Biosciences?
      The latest annual turnover of Neurocrine Biosciences is USD 1.89B
      What is the latest annual profit for Neurocrine Biosciences?
      The latest annual profit of Neurocrine Biosciences is USD 249.7M
      What is the registered address of Neurocrine Biosciences?
      The registered address for Neurocrine Biosciences is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
      What is the Neurocrine Biosciences website address?
      The website address for Neurocrine Biosciences is www.neurocrine.com
      Which industry sector does Neurocrine Biosciences operate in?
      Neurocrine Biosciences operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      GILDGuild Esports Plc
      0.075p
      (66.67%)
      		158.2M
      MSMNMosman Oil And Gas Limited
      0.038p
      (52.00%)
      		2.3B
      MODER8 Capital Investments Plc
      2.10p
      (40.00%)
      		7.75M
      LENDSancus Lending Group Limited
      0.60p
      (33.33%)
      		2.2M
      KMKKromek Group Plc
      6.65p
      (25.47%)
      		41.88M
      FUMFutura Medical Plc
      16.98p
      (-45.23%)
      		8.72M
      RCDORicardo Plc
      263.00p
      (-25.28%)
      		4.42M
      PEGPetards Group Plc
      6.50p
      (-18.75%)
      		1.16M
      SCGLSealand Capital Galaxy Limited
      6.50p
      (-14.47%)
      		6.21M
      SIVSivota Plc
      3.00p
      (-14.29%)
      		7.5k
      MSMNMosman Oil And Gas Limited
      0.038p
      (52.00%)
      		2.3B
      DKEDukemount Capital Plc
      0.055p
      (22.22%)
      		1.4B
      EMEEmpyrean Energy Plc
      0.115p
      (4.55%)
      		917.03M
      TRPTower Resources Plc
      0.0295p
      (3.51%)
      		470.89M
      DGIDg Innovate Plc
      0.0155p
      (-8.82%)
      		344.08M

      Discussion

      View Full Feed
      mrMadMax mrMadMax 3 minutes ago
      🤡The real Clow here is just you pal!!!!!🤡
      ATMH
      100lbStriper 100lbStriper 4 minutes ago
      506 patent, scheduling conflict dates........ https://media.stocktwits-cdn.com/api/3/media/1688627/default.jpeg
      NLST
      janice shell janice shell 4 minutes ago
      Wonder what their dei policies are,,,,,,,you could be posting about it there ;)

      They seem to be about what they are here:

      Building an Inclusive Workplace: Diversity and Inclusion Initiatives in China

      https://hrone.com/blog/inclusive-workplace/
      WorkinGreen WorkinGreen 4 minutes ago
      Tiny SS like this I would be thrilled with anything T5 and under
      GBHL
      OMOLIVES OMOLIVES 5 minutes ago
      More pressure on this issuer now. Better start getting in front of it....already behind.
      HMBL
      RickNagra RickNagra 5 minutes ago
      Oh wow.  Varmit we are headed to the moon.  Please be prepared and we must prepare others for the eventual journey launch trip to the moon and possibly Mars.  They say there is life on Mars.  Probably those people already own GNCC shares.  Not sure how they place the orders though.  Probably use Mar
      GNCP
      cojoboy cojoboy 5 minutes ago
      You woould suc
      IGPK
      MyBuster1966 MyBuster1966 5 minutes ago
      https://x.com/PrincesPats/status/1885016294757457957/photo/1
      HMBL
      splintered sunlight splintered sunlight 6 minutes ago
      The only hope...
      CBLO
      MyBuster1966 MyBuster1966 7 minutes ago
      $YBYRA $HMBL fix your eyes on this patent pending list one of them have already been approved. How many #Blockchain companies can boast of the same? $HMBL is grossly undervalued and picture after
      @EuThiago_Moura
      the new CEO of $HMBL starts adding hard cash to the balance sheet...
      HMBL YBYRA
      Tr8dervic Tr8dervic 8 minutes ago
      Powerball Winning Numbers
      Wed, Jan 29, 2025
      8
      12
      31
      33
      38
      18
      Power Play
      3x
      Estimated Jackpot: $71 Million
      Cash Value: $31.7 Million

      Next Drawing
      Sat, Feb 1, 2025
      Estimated Jackpot
      $89 M
      TenKay TenKay 8 minutes ago
      You are not going to see one. It is somewhat recognizable in the Porsche community and was an “extra” in a movie. It has been modified for the track and is on the internet.

      I use to instruct HPDE with PCA. As much as I like you guys…there are some nutcases out there that would love
      HMBL
      FACT-MASTER FACT-MASTER 9 minutes ago
      Not sure, decided to stop watching and focus on my work related projects and goals - much more satisfying.

      Haven't sold any ESPR, and am the type that will go down with the ship ( if necessary, but hope not).

      I only skim through the st board now, however i like the ide
      ESPR
      Top Penny Top Penny 9 minutes ago
      Calling July 2025 .04 or better, putting my reputation on the line. 100% CONFIDENT!!!

      https://www.youtube.com/watch?v=koVHN6eO4Xg
      PSRU
      jglider jglider 10 minutes ago
      yes and we started the transition to the next ez trade. By Mon we should be done. Insiders and major contributors know what it is. Let market whipsaw all it wants.
      TightCoil TightCoil 10 minutes ago
      No, I like your posts, so does my dog...just kiddin' - I love your posts, but i hate X
      FNMA
      beholder_23 beholder_23 11 minutes ago
      Nobody will pay $20 for this stock. If this company somehow manages to uplist to the NASDAQ it will be shorted into oblivion. This is an easily recognizable scam.

      $BLTH has no money, no offices, no employees, no IT infrastructure, no DLE facilities, no engineers with experience in the
      BLTH
      layton layton 12 minutes ago
      Nobody should ever complain about losing money on Pink Sheets...
      PSRU
      unlimitedgains4 unlimitedgains4 12 minutes ago
      Exciting times but it's not a real product from humbl it's fugazi 🫣😂
      HMBL
      Royal Dude Royal Dude 13 minutes ago
      P' = $10,000 Series OO
      U's = 130 bil ÷ 1.2 bil = 108 per share in Series A
      Sure wish they would tell us so we would not have to guess
      COOP
      RobotDroid RobotDroid 13 minutes ago
      Yeah, try Carolyn. https://apnews.com/article/caroline-robert-kennedy-trump-health-secretary-f01f58305eac53560e31c51aaee5f171
      NWBO
      Jimmy Joe Jimmy Joe 13 minutes ago
      If your smart enough to go back and look at my posts regarding Dr Lowensrein you’ll see you don’t know what your talking about as usual

      Bubbles, go back and read my post. I posted Dr Lowonbrains, not Dr Lowenstein genius.

      Thanks for the belly laugh liar~!
      ELTP

      Your Recent History

      LSE
      0K6R
      Neurocrine Biosciences
      BIT
      UB4QNV
      Unicredit Bank
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads